Rajavelu Esther 4
4 · Spero Therapeutics, Inc. · Filed Nov 12, 2024
Insider Transaction Report
Form 4
Rajavelu Esther
See Remarks
Transactions
- Sale
Common Stock
2024-11-08$1.30/sh−17,245$22,419→ 379,270 total - Sale
Common Stock
2024-11-07$1.31/sh−23,351$30,590→ 396,515 total
Footnotes (1)
- [F1]The reported transaction is a sale of common stock effected to cover tax withholding obligations pursuant to a "sell to cover" provision included in each RSU Agreement in connection with the vesting of RSUs that were granted to the Reporting Person on November 13, 2023.